These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8532752)

  • 1. Problems associated with the use of broad-band illumination sources for photodynamic therapy.
    Stringer MR
    Phys Med Biol; 1995 Oct; 40(10):1733-5. PubMed ID: 8532752
    [No Abstract]   [Full Text] [Related]  

  • 2. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
    Christensen E
    Stomatologija; 2013; 15(3):ii. PubMed ID: 24511763
    [No Abstract]   [Full Text] [Related]  

  • 4. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
    Sotiriou E; Apalla Z; Ioannides D
    Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reader's letter concerning K. Kreutzer, B.Bonnekoh, I. Franke, H. Gollnick. Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (Photdyn 501): practical experiences in problem patients with actinic keratoses and basal cell carcinomas. JDDG 2004,12:992-999].
    Breuninger H
    J Dtsch Dermatol Ges; 2005 May; 3(5):397. PubMed ID: 16372809
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pigmentation on photodynamic therapy.
    Apalla Z; Lallas A; Sotiriou E; Ioannides D
    Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of pigmentation on photodynamic therapy - Authors' reply.
    Arits A; Kelleners-Smeets NW
    Lancet Oncol; 2013 Aug; 14(9):e340. PubMed ID: 23896273
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome.
    Chapas AM; Gilchrest BA
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):3-5. PubMed ID: 16485873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroepithelioma of Pinkus: poor response to topical photodynamic therapy.
    Park MY; Kim YC
    Eur J Dermatol; 2010; 20(1):133-4. PubMed ID: 19919909
    [No Abstract]   [Full Text] [Related]  

  • 11. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
    Nijsten T
    Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
    Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
    Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
    Sebaratnam DF; Venugopal SS; Murrell DF
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
    Arits A; Nelemans P; Kelleners-Smeets N
    Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
    [No Abstract]   [Full Text] [Related]  

  • 16. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light.
    Fink-Puches R; Wolf P; Kerl H
    Arch Dermatol; 1997 Dec; 133(12):1494-5. PubMed ID: 9420532
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating basal-cell carcinoma in a real life setting.
    Dummer R
    Lancet Oncol; 2013 Jun; 14(7):572-3. PubMed ID: 23683749
    [No Abstract]   [Full Text] [Related]  

  • 18. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
    Wolfe CM; Green WH; Hatfield HK; Cognetta AB
    J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesion compression during light activation may improve efficacy of photodynamic treatment of basal cell carcinoma: preliminary results and rationale.
    Stephens R; Holmes J; Eadie E
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e628-e630. PubMed ID: 32311807
    [No Abstract]   [Full Text] [Related]  

  • 20. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.
    de Haas ER; Kruijt B; Sterenborg HJ; Martino Neumann HA; Robinson DJ
    J Invest Dermatol; 2006 Dec; 126(12):2679-86. PubMed ID: 16841035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.